244 related articles for article (PubMed ID: 28884118)
21. Peroxisome proliferator-activated receptors and angiogenesis.
Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
[TBL] [Abstract][Full Text] [Related]
22. P-450 metabolites of arachidonic acid in the control of cardiovascular function.
Roman RJ
Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
24. Role of cytochrome P450 metabolites of arachidonic acid in regulation of corporal smooth muscle tone in diabetic and older rats.
Yousif MH; Benter IF
Vascul Pharmacol; 2007; 47(5-6):281-7. PubMed ID: 17855173
[TBL] [Abstract][Full Text] [Related]
25. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.
Desai A; Victor-Vega C; Gadangi S; Montesinos MC; Chu CC; Cronstein BN
Mol Pharmacol; 2005 May; 67(5):1406-13. PubMed ID: 15673602
[TBL] [Abstract][Full Text] [Related]
26. Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans.
Bellien J; Thuillez C; Joannides R
Fundam Clin Pharmacol; 2008 Aug; 22(4):363-77. PubMed ID: 18705747
[TBL] [Abstract][Full Text] [Related]
27. Animal models for the study of adenosine receptor function.
Yaar R; Jones MR; Chen JF; Ravid K
J Cell Physiol; 2005 Jan; 202(1):9-20. PubMed ID: 15389588
[TBL] [Abstract][Full Text] [Related]
28. An overview on biological mechanisms of PPARs.
Kota BP; Huang TH; Roufogalis BD
Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
[TBL] [Abstract][Full Text] [Related]
29. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
[TBL] [Abstract][Full Text] [Related]
30. Sex Difference in Coronary Endothelial Dysfunction in Apolipoprotein E Knockout Mouse: Role of NO and A2A Adenosine Receptor.
Zhou X; Teng B; Mustafa SJ
Microcirculation; 2015 Oct; 22(7):518-27. PubMed ID: 26201383
[TBL] [Abstract][Full Text] [Related]
31. Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle.
Lynge J; Hellsten Y
Acta Physiol Scand; 2000 Aug; 169(4):283-90. PubMed ID: 10951119
[TBL] [Abstract][Full Text] [Related]
32. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
33. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
34. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
36. The role of adenosine and ATP-sensitive potassium channels in the protection afforded by ischemic preconditioning against the post-ischemic endothelial dysfunction in guinea-pig hearts.
Maczewski M; Beresewicz A
J Mol Cell Cardiol; 1998 Sep; 30(9):1735-47. PubMed ID: 9769229
[TBL] [Abstract][Full Text] [Related]
37. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
Hirano K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716
[TBL] [Abstract][Full Text] [Related]
38. [Neuroprotective mechanisms of adenosine action on CNS neurons].
Zalewska-Kaszubska J
Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
[TBL] [Abstract][Full Text] [Related]
39. Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective.
Simard T; Jung R; Labinaz A; Faraz MA; Ramirez FD; Di Santo P; Pitcher I; Motazedian P; Gaudet C; Rochman R; Marbach J; Boland P; Sarathy K; Alghofaili S; Russo JJ; Couture E; Beanlands RS; Hibbert B
Cardiovasc Hematol Disord Drug Targets; 2019; 19(2):109-131. PubMed ID: 30318008
[TBL] [Abstract][Full Text] [Related]
40. Corrigendum to "Enhancing endogenous adenosine A
Korkutata M; Saitoh T; Cherasse Y; Ioka S; Duo F; Qin R; Murakoshi N; Fujii S; Zhou X; Sugiyama F; Chen JF; Kumagai H; Nagase H; Lazarus M
Neuropharmacology; 2019 Jul; 153():153. PubMed ID: 31101360
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
